Precision medicine in Forward is a comprehensive integration of deep scientific insights, cutting-edge technologies, and rich industry experience. Structure characterization, biophysics techniques and algorithm-based optimization form the foundation of discovery. Expert empirical insights and experiment-based iteration together drives the discovery seed into a well-designed drug. While being a startup biotech, Forward has eyes on unmet medical needs with large market potential from day one in the pursuit of new solutions for patients worldwide. Our first two clinical assets are in lung cancer and breast cancer as a demonstration of our resolution to fulfill the mission.

Forward Pharma became the first strategic partner of WuXi AppTec in Shenzhen.

FWD1509 has completed clinical applications in China and the United States.

FWD1802 has received new drug clinical study applications in China and the United States.